CA2361572A1 - Prevention of abscess formation - Google Patents

Prevention of abscess formation Download PDF

Info

Publication number
CA2361572A1
CA2361572A1 CA002361572A CA2361572A CA2361572A1 CA 2361572 A1 CA2361572 A1 CA 2361572A1 CA 002361572 A CA002361572 A CA 002361572A CA 2361572 A CA2361572 A CA 2361572A CA 2361572 A1 CA2361572 A1 CA 2361572A1
Authority
CA
Canada
Prior art keywords
solution
hyaluronic acid
surgery
surgical procedure
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002361572A
Other languages
English (en)
French (fr)
Inventor
James W. Burns
Eugene Skrabut
Harry Van Goor
Michel M. P. J. Reijnen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNIVERSITY HOSPITAL NIJMEGEN
Genzyme Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2361572A1 publication Critical patent/CA2361572A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • External Artificial Organs (AREA)
CA002361572A 1999-02-04 2000-02-04 Prevention of abscess formation Abandoned CA2361572A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11870799P 1999-02-04 1999-02-04
US60/118,707 1999-02-04
PCT/US2000/002988 WO2000045804A2 (en) 1999-02-04 2000-02-04 Use of a polyanionic polysaccharide solution for the prevention of abscess formation

Publications (1)

Publication Number Publication Date
CA2361572A1 true CA2361572A1 (en) 2000-08-10

Family

ID=22380260

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002361572A Abandoned CA2361572A1 (en) 1999-02-04 2000-02-04 Prevention of abscess formation

Country Status (5)

Country Link
EP (1) EP1148886A2 (de)
JP (1) JP2002536323A (de)
AU (1) AU3356600A (de)
CA (1) CA2361572A1 (de)
WO (1) WO2000045804A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002154906A (ja) * 2000-11-13 2002-05-28 Michio Hayashi 抗菌剤組成物
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
US7238677B2 (en) 2003-03-28 2007-07-03 Kimberly-Clark Worldwide, Inc. Prevention of urogenital infections
EP1911769B1 (de) * 2005-08-04 2013-10-30 Teijin Limited Cellulosederivat
RU2486892C1 (ru) * 2011-11-25 2013-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального обучения "Хакасский государственный университет им. Н.Ф. Катанова" (ФГБОУ ВПО "ХГУ им. Н.Ф.Катанова") Способ лимфотропной терапии при ортодентальных абсцессах у кроликов

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
US5700787A (en) * 1994-09-02 1997-12-23 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
JPH09208476A (ja) * 1996-01-26 1997-08-12 Takada Seiyaku Kk 腹腔内投与用医薬組成物

Also Published As

Publication number Publication date
EP1148886A2 (de) 2001-10-31
AU3356600A (en) 2000-08-25
WO2000045804A3 (en) 2001-03-08
JP2002536323A (ja) 2002-10-29
WO2000045804A2 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
Burns et al. A hyaluronate based gel for the prevention of postsurgical adhesions: evaluation in two animal species
US11000574B2 (en) Hyaluronic acid containing compositions for prevention of the formation of post-surgical scars and post-surgical adhesions
Back et al. Application of hyaluronic acid/sodium alginate-based microparticles to prevent tissue adhesion in a rabbit model
Cheung et al. Adjuvant therapy for the reduction of postoperative intra-abdominal adhesion formation
Murphy et al. Use of a high-molecular-weight carboxymethylcellulose in a tissue protective solution for prevention of postoperative abdominal adhesions in ponies
DK175597B1 (da) Anvendelse af en vævsplasminogenaktivator (t-PA) til fremstilling af et præparat til anvendelse til forebyggelse af fibrinaflejring eller adhærencedannelse eller -gendannelse, topiske præparater og dispenseringsindretninger til.
CA2361572A1 (en) Prevention of abscess formation
Peck et al. Topics and trends in surgical research: evaluation of CMC and HA solutions for adhesiolysis
Reijnen et al. Hyaluronic acid‐based agents do not affect anastomotic strength in the rat colon, in either the presence or absence of bacterial peritonitis
US8158610B2 (en) Dextrin-containing composition for preventing surgical adhesions
JP4276601B2 (ja) 外科手術上の癒着を阻止するためのデキストリンを含有する組成物
EP1001790B1 (de) Zusammensetzung zur schmierung und trennung von geweben und biologischen membranen
US20110293691A1 (en) Multimodal adhesion barrier
van Goor MMP]. Reijnen JFGM Meis VA Postma
Durmus et al. Comparison of the effects of different concentrations of sodium carboxymethylcellulose on prevention of intraabdominal adhesions in rats
Akçıl et al. Composing an Adhesion Barrier Using Hyaluronic Acid and Carboxymethylcellulose to Prevent Mediastinal Adhesion
Sikkink et al. Hyaluronan-based antiadhesive agents in abdominal surgery: applications, results, and mechanisms of action
Goldberg Tissue-protective solutions and films for adhesion prevention
US5589169A (en) Method and therapeutic compositions for the prevention of fibrin deposition or adhesions
Reijnen et al. Hyaluronan-based agents do not affect anastomotic strength in the rat colon, in either the
KR101349200B1 (ko) 헥소사민 화합물 또는 이의 약학적으로 허용 가능한 염을포함하는, 수술 후 유착의 예방 또는 치료용 약학 조성물
Burns et al. Hyaluronan-Based Membrane for the Prevention of Postsurgical Adhesions
Sikkink et al. Applications, Results, and Mechanisms of Action

Legal Events

Date Code Title Description
FZDE Dead